| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.011 | 0.9 |